Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Tolusso

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Autoimmunity Reviews|November 24, 2007
Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settingsGianfranco Ferraccioli, Barbara Tolusso
Arthritis Research & Therapy|June 4, 2016
Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?Gianfranco Ferraccioli, Barbara Tolusso, Elisa Gremese
Pharmacogenomics|December 9, 2004
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatologyGianfranco Ferraccioli, Maria De Santis, Barbara Tolusso
Rheumatology (Oxford, England)|May 8, 2026
Synovial biopsy and tissue sampling in the management of rheumatoid arthritisDario Bruno, Barbara Tolusso, Elisa Gremese, et al.
Frontiers in Immunology|November 27, 2014
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)Elisa Gremese, Barbara Tolusso, Maria Rita Gigante, et al.
Autoimmunity Reviews|April 22, 2022
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsideredElisa Gremese, Barbara Tolusso, Dario Bruno, et al.
European Journal of Clinical Investigation|July 10, 2020
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseasesElisa Gremese, Edoardo Sean Ferraccioli, Stefano Alivernini, et al.
Expert Review of Clinical Immunology|March 8, 2016
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerationsBarbara Tolusso, Stefano Alivernini, Maria Rita Gigante, et al.
Journal of Leukocyte Biology|July 18, 2019
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapyElisa Gremese, Stefano Alivernini, Barbara Tolusso, et al.
Annals of the Rheumatic Diseases|November 25, 2010
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritisGiusy Peluso, Alessandro Michelutti, Silvia Bosello, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Autoimmunity Reviews|November 24, 2007
Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settingsGianfranco Ferraccioli, Barbara Tolusso
Arthritis Research & Therapy|June 4, 2016
Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?Gianfranco Ferraccioli, Barbara Tolusso, Elisa Gremese
Pharmacogenomics|December 9, 2004
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatologyGianfranco Ferraccioli, Maria De Santis, Barbara Tolusso
Rheumatology (Oxford, England)|May 8, 2026
Synovial biopsy and tissue sampling in the management of rheumatoid arthritisDario Bruno, Barbara Tolusso, Elisa Gremese, et al.
Frontiers in Immunology|November 27, 2014
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)Elisa Gremese, Barbara Tolusso, Maria Rita Gigante, et al.
Autoimmunity Reviews|April 22, 2022
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsideredElisa Gremese, Barbara Tolusso, Dario Bruno, et al.
European Journal of Clinical Investigation|July 10, 2020
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseasesElisa Gremese, Edoardo Sean Ferraccioli, Stefano Alivernini, et al.
Expert Review of Clinical Immunology|March 8, 2016
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerationsBarbara Tolusso, Stefano Alivernini, Maria Rita Gigante, et al.
Journal of Leukocyte Biology|July 18, 2019
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapyElisa Gremese, Stefano Alivernini, Barbara Tolusso, et al.
Annals of the Rheumatic Diseases|November 25, 2010
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritisGiusy Peluso, Alessandro Michelutti, Silvia Bosello, et al.
Pageof 10